Structure-aware generalization for heterogeneous histopathology via prototype-based multiple instance learning.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41540138.
- Also identified by DOI 10.1038/s41746-025-02289-4 and PMC identifier 12864818.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Accurate and generalizable cancer diagnosis from whole slide images (WSIs) remains challenging due to limited fine-grained annotations, complex tumor architectures, and domain shifts across scanners and institutions<sup>1</sup>. We introduce StructMIL, a structure-aware and prototype-driven multiple instance learning framework designed for robust and interpretable cancer detection and grading<sup>2</sup>. StructMIL integrates graph-based topological priors with histological context, employs prototype-enhanced pooling for stable and transparent predictions, and incorporates a unified domain-generalization strategy that combines contrastive alignment, adversarial confusion, and consistency regularization. Evaluated on Camelyon16 for breast cancer metastasis detection and PANDA for prostate cancer Gleason grading, StructMIL achieves state-of-the-art performance. On Camelyon16, StructMIL improves cross-center AUC by +3.2% over standard MIL baselines, reaching an AUC of 0.967. On PANDA, it improves cross-scanner Gleason grading robustness with a +7.4% Cohen's Kappa gain compared with prior MIL models, demonstrating substantially reduced performance degradation under domain shift. StructMIL further provides interpretable prototype-based attribution maps that highlight biologically meaningful structures more reliably than conventional MIL and graph-free approaches<sup>3</sup>. By jointly improving accuracy, interpretability, and generalization across scanners and medical centers, StructMIL offers a practical and clinically aligned solution for large-scale deployment in multi-center computational pathology workflows<sup>4</sup>.